Lowe's Companies Equity Method Investments increased by 13.9% to $319.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.2%, from $277.00M to $319.00M. Over 5 years (FY 2021 to FY 2026), Equity Method Investments shows an upward trend with a 6.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $197.00M | $225.00M | $213.00M | $199.00M | $76.00M | $56.00M | $63.00M | $121.00M | $103.00M | $182.00M | $238.00M | $252.00M | $306.00M | $292.00M | $312.00M | $277.00M | $300.00M | $273.00M | $280.00M | $319.00M |
| QoQ Change | — | +14.2% | -5.3% | -6.6% | -61.8% | -26.3% | +12.5% | +92.1% | -14.9% | +76.7% | +30.8% | +5.9% | +21.4% | -4.6% | +6.8% | -11.2% | +8.3% | -9.0% | +2.6% | +13.9% |
| YoY Change | — | — | — | — | -61.4% | -75.1% | -70.4% | -39.2% | +35.5% | +225.0% | +277.8% | +108.3% | +197.1% | +60.4% | +31.1% | +9.9% | -2.0% | -6.5% | -10.3% | +15.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.